Insulin Glargine (U-300) Pens and Seebri Neohaler
Determining the interaction of Insulin Glargine (U-300) Pens and Seebri Neohaler and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: glycopyrrolate
Brand name: Lonhala Magnair Starter Kit, Seebri Neohaler, Cuvposa, GLYRX-PF, Robinul, Robinul Forte
Synonyms: Seebri Neohaler (inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Seebri Neohaler inhalation
- Insulin Glargine (U-300) Pens-Segesterone Acetate and Ethinyl Estradiol
- Insulin Glargine (U-300) Pens-Segesterone acetate and ethinyl estradiol Vaginal
- Insulin Glargine (U-300) Pens-Segluromet
- Insulin Glargine (U-300) Pens-Seizalam Injection
- Insulin Glargine (U-300) Pens-Seldane
- Seebri Neohaler-Insulin glargine and lixisenatide
- Seebri Neohaler-Insulin glargine and lixisenatide Subcutaneous
- Seebri Neohaler-Insulin glargine, recombinant Subcutaneous
- Seebri Neohaler-Insulin glulisine
- Seebri Neohaler-Insulin Glulisine (Cartridges and Pens)
- Seebri Neohaler-Insulin Glulisine (Vials)